TOKYO, May 01 (Pulse News Wire) – M3,inc. (2413.T) reported robust performance for fiscal year 2025, achieving revenue of ¥132 billion and operating profit of ¥1.34 billion, marking a significant increase from the previous year.
Despite recording impairment losses totaling ¥14 million due to changes in medical policies and vaccine-related cancellations, the company's existing businesses continued to grow steadily, contributing to record-high operating profits. In detail, the Medical Platform division saw revenue rise to ¥87.00 billion, while Evidence Solution and Career Solution divisions posted revenues of ¥24 billion and ¥23 billion respectively. The Patient Solution division also showed substantial growth, reaching ¥54 billion in revenue.
Overseas operations contributed ¥18.00 billion to total sales, reflecting a resilient performance across various regions despite challenges in certain markets. Looking ahead, M3 plans to leverage artificial intelligence further to enhance operational efficiency and create additional value. The company expects AI to positively impact its operations in numerous fields, potentially expanding its influence beyond current activities.
Additionally, M3 intends to continue investing in mergers and acquisitions to drive future growth, aiming to expand its global footprint and deepen its service offerings.
🔴 Confidence: Review recommended AI-translated content.